NE Elliott, SM Cleveland, V Grann, J Janik… - Blood, 2011 - ncbi.nlm.nih.gov 1. Blood. 2011 Aug 5. [Epub ahead of print] FERM domain mutations induce gain of function in JAK3 in adult T-cellleukemia/lymphoma. ... Adult T-cellleukemia/lymphoma (ATLL) is an incurable disease where most patients succumb within the first year of diagnosis. ...
[HTML] from hematologylibrary.orgT Hisatomi, N Sueoka-Aragane… - …, 2011 - bloodjournal.hematologylibrary.org NK314 potentiates antitumor activity with adult T-cellleukemia-lymphomacells by inhibition of dual targets on topoisomerase IIα and DNA-dependent protein kinase. ... Abstract. Adult T-cell leukemia-lymphoma (ATL) is an aggressive disease, incurable by standard chemotherapy. ... Related articles - All 3 versions
[PDF] from nagasaki-u.ac.jpH Hasegawa, Y Yamada, K Tsukasaki, N Mori… - Leukemia, 2011 - nature.com ... LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cellleukemia/lymphomacells via activation of a novel RAIDD-caspase-2 pathway Open. ... LBH589 causes acetylation of histones and non-histone proteins in adult T-cellleukemia/lymphoma (ATLL) cells. ... Cited by 1 - Related articles - All 6 versions
[HTML] from haematologica.itL Wang, WY Shi, F Yang, W Tang, G Gapihan… - …, 2011 - haematologica.it ... 2009;6 9: 507–18.[CrossRef][Web of Science][Medline]; Avramis IA, Panosyan EH ... and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from ... both on lymphomacells and endothelial cells in angioimmunoblastic T-celllymphoma and related ... Related articles - All 12 versions
H Hasegawa, M Komoda, Y Yamada… - … & Lymphoma, 2011 - informahealthcare.com ... Aberrant overexpression of membrane-associated mucin contributes to tumor progression in adult T-cellleukemia/lymphomacells. June 2011, Vol. 52, No. ... Possible origin of adult T-cell leukemia/lymphomacells from human T lymphotropic virus type-1-infected regulatory T cells. ... Related articles - All 3 versions